Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-03

Clinical Trial Update: Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex [Phase 2]

View source ↗

Summary

Phase 2 trial comparing ddI and zidovudine in AIDS dementia complex and HIV infection; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Didanosine (didanosine)
  • Zidovudine (Zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: AIDS Dementia Complex, HIV Infections | Phase 2 | Status: COMPLETED